Quaker Chemical (KWR) Cash & Equivalents (2010 - 2026)

Quaker Chemical (KWR) has reported Cash & Equivalents for 17 consecutive years, with $155.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 23.19% year-over-year to $155.1 million in Q2 2026; TTM through Jun 2026 was $155.1 million, a 23.19% decrease from a year earlier, with the FY2025 full-year figure at $179.8 million, down 4.79% from the prior year.
• Cash & Equivalents was $155.1 million for Q2 2026 at Quaker Chemical, down from $169.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $212.1 million in Q3 2024 and troughed at $138.9 million in Q3 2022.
• A 5-year average of $183.7 million and a median of $188.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 42.82% in 2023 and slipped 23.19% in 2026, its largest moves.
• Over 5 years, Cash & Equivalents stood at $181.0 million in 2022, then rose by 7.5% to $194.5 million in 2023, then retreated by 2.9% to $188.9 million in 2024, then fell by 4.79% to $179.8 million in 2025, then fell by 13.76% to $155.1 million in 2026.
• The last three Cash & Equivalents figures came in at $155.1 million (Q2 2026), $169.7 million (Q1 2026), and $179.8 million (Q4 2025), per Business Quant data.